| Prev Close | 249.31 |
| Day Low/High | 246.35 / 254.50 |
| 52 Wk Low/High | 233.71 / 333.96 |
Danaher Corporation (DHR)
251.80
NYSE
| Exchange | NYSE |
| Shares Outstanding | 727.08B |
| Market Cap | 181.27B |
| P/E Ratio | 55.62 |
| Div & Yield | N.A. (N.A) |
Latest News
Bulls Will Have to Go Further Down Creek With Danaher
The longer-term trend of DHR is bullish, but we first must deal with the sideways action.
The Market's B-Team Names Bounce
We're seeing laggards rise, while some S&P stars are sliding.
GE and JNJ Aren't the Only Aging Companies That Could Benefit From a Breakup
These moves could serve as a benchmark for other bigger, older, and perhaps bloated companies. Here are some candidates.
A Technical Take on the S&P 500
As we gear into a very heavy earnings week next week - more on that later - that also includes the Fed's next monetary policy meeting, I asked my Trifecta Stocks partner Bob Lang to give us a technical take on the S&P 500... take it away Bob: SPX 50...
Crypto Pep Rally, S&P Wonder Line, Minerd Unmuted, Chip Keepers, Trading Moderna
Small-caps and mid-caps are still picking first downs on every play, storming back from a badly oversold condition that has just about normalized.
Danaher's Chart Signals a Breakout Trade
The maker of medical and industrial products had been underperforming the broader market but looks primed to move higher.
The Hour Glass Phenomena, Oh Canada, Portfolio Haircut, Earth Day, ESG Investing
Canada made the developed world's first moves toward normalizing monetary policy coming out of the pandemic, despite the fact that Canada does not seem to be flattening its own curve.
There's No Way I'm Ready to Sell General Electric
There's a whole lotta lovin' going around this name.
Jim Cramer: There's Good Risk and Bad Risk
Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
Danaher Could Trade Higher
I do not find enough technical reasons to recommend new long positions at this point in time.
4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine
Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?
PerkinElmer Could Rally Further After a Big Consolidation Breakout
The charts of the life sciences company suggest its stock could make a large upside move.
Sector Haves/Have Nots, Lisa Su Does It Again, Trading Tesla and Microsoft
Earnings reports continue to outperform, but can this support equity markets at these levels now?
Jim Cramer: 20 Stocks That Are Emblematic of What's Driving the Market
This list is not a buy list but a list of stocks that have been brought to new heights.
Trading Volume, Late Selloffs, Peloton's Run Higher
As Treasury heads for longer-dated issuance and names like PTON run higher on earnings, selloffs late in the trading day continue.
Institutions Hold Fire, Abbott Labs Strategy, Zscaler Breakout
Despite the dramatic and highly negative decline in economic activity that forced algos to hit the markets from above, enough portfolio managers faded that move to lessen its impact.
6 Testing, Diagnostics and Medical Devices Stocks You Should Know About
Look for weaknesses in companies like these that can provide solutions to today's pressing issues.
No Rush to Buy General Electric but Here's a Trade Idea
I would not take an equity stake without messing around with net basis through the sale of what look to me to be well placed options mean to force profit taking, and/or adding at advantageous discounts.
Thermo Fisher Scientific Could Trade Higher in the Weeks and Months Ahead
The charts of TMO are positive.
I'd Be Hesitant Chasing General Electric Stock at These Levels
The company needs to continue to reduce debt and strengthen its balance sheet.
Danaher Looks Like It Could Stall or Turn Lower
Prices appear to be losing upward momentum and overbought when using the stochastic indicator, so caution is in order.
Keep Danaher Under Observation for Now
For this science and technology company, it's hard to see a pattern that justifies going long right away.
GE's Still Got Street Cred as Goes on Debt Diet
Despite getting hit with allegations last week, General Electric still has name, history and size.
Railroaded Transports, Musk's AI Musings and Microsoft at Hand: Market Recon
And just why do we have a federal debt ceiling, anyway? An argument for doing away with it.
Jim Cramer: Don't Play Earnings Season, Invest in It
Here are my five rules for handling earnings season.
Bought Danaher on the June Dip? Here's the Path Forward
Those long on DHR should continue to hold, risking a close below $135 -- around $185 is a potential upside price target.
Danaher Could Dip Near-Term, Providing a Buying Opportunity
DHR shares are up 35% in 2019.
